SCHEMBL25354606

SCHEMBL25354606

CNC(Cc1cccc(C)c1C)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.46
ITGB2 P05107 3/20 0.42
ICAM1 P05362 3/20 0.42
ITGAL P20701 3/20 0.42
POLB P06746 2/20 0.42
MEN1 O00255 1/20 0.42
MAPT P10636 1/20 0.42
KMT2A Q03164 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NR3C1 P04150 1/20 0.40
PGR P06401 1/20 0.40
NR3C2 P08235 1/20 0.40
KDM4C Q9H3R0 1/20 0.40
TP53 P04637 1/20 0.39
ITGB1 P05556 2/20 0.38
ITGA4 P13612 2/20 0.38
PSMB1 P20618 1/20 0.38
PSMB5 P28074 1/20 0.38
PSMB2 P49721 1/20 0.38
PTGS2 P35354 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25354603 1.00 L3MBTL1 (0.46) L3MBTL1ITGB2ICAM1ITGALPOLB
SCHEMBL22133172 0.87 NR3C1 (0.40) L3MBTL1ITGB2ICAM1ITGALPOLB
SCHEMBL27977570 0.87 PPARG (0.48) L3MBTL1ITGB2ICAM1ITGALKMT2A
SCHEMBL29855148 0.87 PPARG (0.48) L3MBTL1ITGB2ICAM1ITGALKMT2A
SCHEMBL16203412 0.87 PPARG (0.48) L3MBTL1ITGB2ICAM1ITGALKMT2A
SCHEMBL10065590 0.87 PPARG (0.48) L3MBTL1ITGB2ICAM1ITGALKMT2A
SCHEMBL38327 0.81 L3MBTL1 (0.49) L3MBTL1ITGB2ICAM1ITGALPOLB
SCHEMBL8053590 0.81 KMT2A (0.50) L3MBTL1MEN1KMT2ANR3C1PGR
SCHEMBL7382016 0.80 PPARG (0.48) L3MBTL1NR3C1PGRNR3C2KDM4C
SCHEMBL24899379 0.78 L3MBTL1 (0.46) L3MBTL1POLBMAPTNR3C1PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2023-08-17 US claimed
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2023-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES DNPEP, BCAT1, ANPEP L3MBTL1 1836/4885ITGB2 3684/4885ICAM1 3346/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.